NCT04792463 2026-03-09Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition SyndromeOhio State UniversityRecruiting500 enrolled
NCT04336241 2026-02-27Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid TumorsReplimune Inc.Phase 1 Active not recruiting36 enrolled
NCT03947385 2026-01-27Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsIDEAYA BiosciencesPhase 1/2 Recruiting336 enrolled
NCT05075993 2025-12-26Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsM.D. Anderson Cancer CenterPhase 1 Active not recruiting352 enrolled
NCT04130516 2025-12-18Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With PembrolizumabLinnaeus Therapeutics, Inc.Phase 1/2 Recruiting200 enrolled
NCT06805825 2025-09-23A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-KitNovelty Nobility, Inc.Phase 1 Recruiting67 enrolled